Nonalcoholic fatty liver disease, spleen and psoriasis: New aspects of low-grade chronic inflammation

World Journal of Gastroenterology

Volumn 21, Issue 22, 2015, Pages 6892-6897

  Balato, Nicola ^a   Napolitano, Maddalena ^a   Ayala, Fabio ^a   Patruno, Cataldo ^a   Megna, Matteo ^a   Tarantino, Giovanni ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Hepatic steatosis; Inflammation; Nonalcoholic fatty liver disease; Psoriasis; Spleen size

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYCLOSPORIN A; ETRETIN; METHOTREXATE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CHRONIC INFLAMMATION; CONTROLLED STUDY; DISEASE DURATION; ECHOGRAPHY; FEMALE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NONALCOHOLIC FATTY LIVER; OBESITY; PHOTOTHERAPY; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; RETROSPECTIVE STUDY; SPLEEN SIZE; WAIST CIRCUMFERENCE; ADOLESCENT; DIAGNOSTIC IMAGING; MIDDLE AGED; ORGAN SIZE; PREDICTIVE VALUE; SEVERITY OF ILLNESS INDEX; SPLEEN; YOUNG ADULT; BODY HEIGHT; BODY WEIGHT; DISEASE CLASSIFICATION; DISEASE SEVERITY; ECHOGRAPH; HEALTH STATUS; ONSET AGE; POPULATION BASED CASE CONTROL STUDY; PREDICTION; SEX;

ADOLESCENT; ADULT; AGED; BODY MASS INDEX; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; ORGAN SIZE; PREDICTIVE VALUE OF TESTS; PSORIASIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPLEEN; ULTRASONOGRAPHY; YOUNG ADULT;

EID: 84930840214     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i22.6892     Document Type: Article

References (26)

1. Langley RG, Krueger GG, Griffiths CE. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005; 64 Suppl 2: ii18-i23; discussion ii18-i23; [PMID: 15708928 DOI: 10.1136/ ard.2004.033217]
2. Kupetsky EA, Keller M. Psoriasis vulgaris: an evidence-based guide for primary care. J Am Board Fam Med 2012; 26: 787-801 [PMID: 24204077 DOI: 10.3122/jabfm.2013.06.130055]
3. Patruno C, Ayala F, Megna M, Napolitano M, Balato N. Patientphysician relationship in patients with psoriasis. Indian J Dermatol Venereol Leprol 2013; 78: 228 [PMID: 22421670 DOI: 10.4103/0378-6323.93657]
4. Dowlatshahi EA, van der Voort EA, Arends LR, Nijsten T. Markers of systemic inflammation in psoriasis: a systematic review and metaanalysis. Br J Dermatol 2013; 169: 266-282 [PMID: 23550658 DOI: 10.1111/bjd.12355]
5. Balato A, Di Caprio R, Canta L, Mattii M, Lembo S, Raimondo A, Schiattarella M, Balato N, Ayala F. IL-33 is regulated by TNF-α in normal and psoriatic skin. Arch Dermatol Res 2014; 306: 299-304 [PMID: 24522896 DOI: 10.1007/s00403-014-1447-9]
6. Ghazizadeh R, Shimizu H, Tosa M, Ghazizadeh M. Pathogenic mechanisms shared between psoriasis and cardiovascular disease. Int J Med Sci 2010; 7: 284-289 [PMID: 20827428]
7. Davidovici BB, Sattar N, Prinz J, Puig L, Emery P, Barker JN, van de Kerkhof P, Stahle M, Nestle FO, Girolomoni G, Krueger JG. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol 2010; 130: 1785-1796 [PMID: 20445552 DOI: 10.1038/ jid.2010.103]
8. van der Voort EA, Koehler EM, Dowlatshahi EA, Hofman A, Stricker BH, Janssen HL, Schouten JN, Nijsten T. Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study. J Am Acad Dermatol 2014; 70: 517-524 [PMID: 24373781 DOI: 10.1016/j.jaad.2013.10.044]
9. Tarantino G, Savastano S, Colao A. Hepatic steatosis, lowgrade chronic inflammation and hormone/growth factor/adipokine imbalance. World J Gastroenterol 2010; 16: 4773-4783 [PMID: 20939105 DOI: 10.3748/wjg.v16.i38.4773]
10. Tsushima Y, Endo K. Spleen enlargement in patients with nonalcoholic fatty liver: correlation between degree of fatty infiltration in liver and size of spleen. Dig Dis Sci 2000; 45: 196-200 [PMID: 10695635]
11. Tarantino G, Colicchio P, Conca P, Finelli C, Di Minno MN, Tarantino M, Capone D, Pasanisi F. Young adult obese subjects with and without insulin resistance: what is the role of chronic inflammation and how to weigh it non-invasively? J Inflamm (Lond) 2009; 6: 6 [PMID: 19291292 DOI: 10.1186/1476-9255-6-6]
12. Tarantino G, Conca P, Pasanisi F, Ariello M, Mastrolia M, Arena A, Tarantino M, Scopacasa F, Vecchione R. Could inflammatory markers help diagnose nonalcoholic steatohepatitis? Eur J Gastroenterol Hepatol 2009; 21: 504-511 [PMID: 19318968 DOI: 10.1097/MEG.0b013e3283229b40]
13. Webb M, Yeshua H, Zelber-Sagi S, Santo E, Brazowski E, Halpern Z, Oren R. Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis. AJR Am J Roentgenol 2009; 192: 909-914 [PMID: 19304694 DOI: 10.2214/AJR.07.4016]
14. Breslow NE, Day NE. Classical Methods of Analysis of Matched Data. In: Breslow NE, Day NE, editors. Statistical methods in cancer research. Volume 1-The analysis of case-control studies. Lyon, France: International Agency for Research on Cancer, 1980: 162-192
15. Christophers E. Comorbidities in psoriasis. J Eur Acad Dermatol Venereol 2006; 20: 52-55
16. Balato N, Balato A, Gallo L, Napolitano M, Patruno C, Ayala F. Psoriasis and osteoporosis: data from a Southern Italian population. Arch Osteoporos 2012; 7: 321-323 [PMID: 23203734]
17. Miller IM, Ellervik C, Yazdanyar S, Jemec GB. Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors. J Am Acad Dermatol 2013; 69: 1014-1024 [PMID: 24238156 DOI: 10.1016/j.jaad.2013.06.053]
18. Boehncke WH, Boehncke S, Schön MP. Managing comorbid disease in patients with psoriasis. BMJ 2010; 340: b5666 [PMID: 20080817 DOI: 10.1136/bmj.b5666]
19. Savastano S, Balato N, Gaudiello F, Di Somma C, Brancato V, Colao A, Ayala F, Tarantino G. Insulin-like growth factor-1, psoriasis, and inflammation: a ménage à trios? European J of Inflammation 2011; 9: 277-284
20. Hamminga EA, van der Lely AJ, Neumann HA, Thio HB. Chronic inflammation in psoriasis and obesity: implications for therapy. Med Hypotheses 2006; 67: 768-773 [PMID: 16781085 DOI: 10.1016/ j.mehy.2005.11.050]
21. Dameshek W. Hypersplenism. Bull N Y Acad Med 1955; 31: 113-136 [PMID: 13230762]
22. Lamas O, Martínez JA, Marti A. Decreased splenic mRNA expression levels of TNF-alpha and IL-6 in diet-induced obese animals. J Physiol Biochem 2004; 60: 279-283 [PMID: 15957247]
23. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 2004; 22: 929-979 [PMID: 15032600 DOI: 10.1146/ annurev.immunol.22.012703.104622]
24. Gotoh K, Inoue M, Masaki T, Chiba S, Shimasaki T, Ando H, Fujiwara K, Katsuragi I, Kakuma T, Seike M, Sakata T, Yoshimatsu H. A novel anti-inflammatory role for spleen-derived interleukin-10 in obesity-induced inflammation in white adipose tissue and liver. Diabetes 2012; 61: 1994-2003 [PMID: 22648387 DOI: 10.2337/ db11-1688]
25. Asadullah K, Sterry W, Stephanek K, Jasulaitis D, Leupold M, Audring H, Volk HD, Döcke WD. IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. J Clin Invest 1998; 101: 783-794 [PMID: 9466973 DOI: 10.1172/JCI1476]
26. Palmentieri B, de Sio I, La Mura V, Masarone M, Vecchione R, Bruno S, Torella R, Persico M. The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Liver Dis 2006; 38: 485-489 [PMID: 16716779]